Literature DB >> 32446278

N-Terminal PreS1 Sequence Regulates Efficient Infection of Cell-Culture-Generated Hepatitis B Virus.

Asako Murayama1, Norie Yamada1, Yoshiki Osaki1, Masaaki Shiina1,2, Hussein Hassan Aly1, Masashi Iwamoto1, Senko Tsukuda1,3, Koichi Watashi1, Mami Matsuda1, Ryosuke Suzuki1, Tomohisa Tanaka4, Kohji Moriishi4, Tetsuro Suzuki5, Hironori Nishitsuji6, Masaya Sugiyama6, Masashi Mizokami6, Kunitada Shimotohno6, Takaji Wakita1, Masamichi Muramatsu1, T Jake Liang7, Takanobu Kato1.   

Abstract

BACKGROUND AND AIMS: An efficient cell-culture system for hepatitis B virus (HBV) is indispensable for research on viral characteristics and antiviral reagents. Currently, for the HBV infection assay in cell culture, viruses derived from HBV genome-integrated cell lines of HepG2.2.15 or HepAD-38 are commonly used. However, these viruses are not suitable for the evaluation of polymorphism-dependent viral characteristics or resistant mutations against antiviral reagents. HBV obtained by the transient transfection of the ordinary HBV molecular clone has limited infection efficiencies in cell culture. APPROACH AND
RESULTS: We found that an 11-amino-acid deletion (d11) in the preS1 region enhances the infectivity of cell-culture-generated HBV (HBVcc) to sodium taurocholate cotransporting polypeptide-transduced HepG2 (HepG2/NTCP) cells. Infection of HBVcc derived from a d11-introduced genotype C strain (GTC-d11) was ~10-fold more efficient than infection of wild-type GTC (GTC-wt), and the number of infected cells was comparable between GTC-d11- and HepG2.2.15-derived viruses when inoculated with the same genome equivalents. A time-dependent increase in pregenomic RNA and efficient synthesis of covalently closed circular DNA were detected after infection with the GTC-d11 virus. The involvement of d11 in the HBV large surface protein in the enhanced infectivity was confirmed by an HBV reporter virus and hepatitis D virus infection system. The binding step of the GTC-d11 virus onto the cell surface was responsible for this efficient infection.
CONCLUSIONS: This system provides a powerful tool for studying the infection and propagation of HBV in cell culture and also for developing the antiviral strategy against HBV infection.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32446278      PMCID: PMC8527393          DOI: 10.1002/hep.31308

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  23 in total

Review 1.  Present and future therapies of hepatitis B: From discovery to cure.

Authors:  T Jake Liang; Timothy M Block; Brian J McMahon; Marc G Ghany; Stephan Urban; Ju-Tao Guo; Stephen Locarnini; Fabien Zoulim; Kyong-Mi Chang; Anna S Lok
Journal:  Hepatology       Date:  2015-10-27       Impact factor: 17.425

2.  A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.

Authors:  L Stuyver; S De Gendt; C Van Geyt; F Zoulim; M Fried; R F Schinazi; R Rossau
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

Review 3.  Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-03-27

4.  Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens.

Authors:  Masaya Sugiyama; Yasuhito Tanaka; Takanobu Kato; Etsuro Orito; Kiyoaki Ito; Subrat K Acharya; Robert G Gish; Anna Kramvis; Takashi Shimada; Namiki Izumi; Masahiko Kaito; Yuzo Miyakawa; Masashi Mizokami
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

5.  Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinoma.

Authors:  Yuichiro Suzuki; Shinya Maekawa; Nobutoshi Komatsu; Mitsuaki Sato; Akihisa Tatsumi; Mika Miura; Shuya Matsuda; Masaru Muraoka; Natsuko Nakakuki; Hiroko Shindo; Fumitake Amemiya; Shinichi Takano; Mitsuharu Fukasawa; Yasuhiro Nakayama; Tatsuya Yamaguchi; Taisuke Inoue; Tadashi Sato; Minoru Sakamoto; Atsuya Yamashita; Kohji Moriishi; Nobuyuki Enomoto
Journal:  Hepatol Res       Date:  2018-12-27       Impact factor: 4.288

6.  Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes.

Authors:  H Okamoto; F Tsuda; H Sakugawa; R I Sastrosoewignjo; M Imai; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1988-10       Impact factor: 3.891

7.  Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.

Authors:  Andreas Schulze; Philippe Gripon; Stephan Urban
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

Review 8.  Development of Direct-acting Antiviral and Host-targeting Agents for Treatment of Hepatitis B Virus Infection.

Authors:  Yuchen Xia; T Jake Liang
Journal:  Gastroenterology       Date:  2018-09-19       Impact factor: 22.682

9.  Resistance mutations of hepatitis B virus in entecavir-refractory patients.

Authors:  Norie Yamada; Ryuichi Sugiyama; Sayuri Nitta; Asako Murayama; Minoru Kobayashi; Chiaki Okuse; Michihiro Suzuki; Kiyomi Yasuda; Hiroshi Yotsuyanagi; Kyoji Moriya; Kazuhiko Koike; Takaji Wakita; Takanobu Kato
Journal:  Hepatol Commun       Date:  2017-03-09

10.  Investigating the hepatitis B virus life cycle using engineered reporter hepatitis B viruses.

Authors:  Hironori Nishitsuji; Keisuke Harada; Saneyuki Ujino; Jing Zhang; Michinori Kohara; Masaya Sugiyama; Masashi Mizokami; Kunitada Shimotohno
Journal:  Cancer Sci       Date:  2017-12-07       Impact factor: 6.716

View more
  10 in total

1.  Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1.

Authors:  Keigo Yato; Taishi Onodera; Mami Matsuda; Saya Moriyama; Akira Fujimoto; Koichi Watashi; Hideki Aizaki; Tomohisa Tanaka; Kohji Moriishi; Hironori Nishitsuji; Kunitada Shimotohno; Koji Tamura; Yoshimasa Takahashi; Takaji Wakita; Masamichi Muramatsu; Takanobu Kato; Ryosuke Suzuki
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

Review 2.  Entry Inhibitors of Hepatitis B and D Viruses.

Authors:  Yang Yang; Youhua Xie
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  Hepatitis B Virus Entry into Cells.

Authors:  Charline Herrscher; Philippe Roingeard; Emmanuelle Blanchard
Journal:  Cells       Date:  2020-06-18       Impact factor: 6.600

4.  Molecular clones of genetically distinct hepatitis B virus genotypes reveal distinct host and drug treatment responses.

Authors:  Yongzhen Liu; Debby Park; Thomas R Cafiero; Yaron Bram; Vasuretha Chandar; Anna Tseng; Hans P Gertje; Nicholas A Crossland; Lishan Su; Robert E Schwartz; Alexander Ploss
Journal:  JHEP Rep       Date:  2022-07-09

5.  Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen.

Authors:  Ayaka Washizaki; Asako Murayama; Megumi Murata; Tomoko Kiyohara; Keigo Yato; Norie Yamada; Hussein Hassan Aly; Tomohisa Tanaka; Kohji Moriishi; Hironori Nishitsuji; Kunitada Shimotohno; Yasumasa Goh; Ken J Ishii; Hiroshi Yotsuyanagi; Masamichi Muramatsu; Koji Ishii; Yoshimasa Takahashi; Ryosuke Suzuki; Hirofumi Akari; Takanobu Kato
Journal:  Nat Commun       Date:  2022-09-05       Impact factor: 17.694

Review 6.  Envelope Proteins of Hepatitis B Virus: Molecular Biology and Involvement in Carcinogenesis.

Authors:  Jun Inoue; Kosuke Sato; Masashi Ninomiya; Atsushi Masamune
Journal:  Viruses       Date:  2021-06-11       Impact factor: 5.048

7.  The Genotype (A to H) Dependent N-terminal Sequence of HBV Large Surface Protein Affects Viral Replication, Secretion and Infectivity.

Authors:  Guomin Ou; Lingyuan He; Luwei Wang; Ji Song; Xinyuan Lai; Xing Tian; Lei Wang; Kai Zhang; Xuechao Zhang; Juan Deng; Hui Zhuang; Kuanhui Xiang; Tong Li
Journal:  Front Microbiol       Date:  2021-07-09       Impact factor: 5.640

8.  The Regulation of circRNA RNF13/miRNA-1224-5p Axis Promotes the Malignant Evolution in Acute Myeloid Leukemia.

Authors:  Rong Zhang; Yingchun Li; Hongtao Wang; Ke Zhu; Guojun Zhang
Journal:  Biomed Res Int       Date:  2020-10-06       Impact factor: 3.411

Review 9.  Innovative HBV Animal Models Based on the Entry Receptor NTCP.

Authors:  Jochen M Wettengel; Benjamin J Burwitz
Journal:  Viruses       Date:  2020-07-30       Impact factor: 5.048

Review 10.  Novel Genetic Rearrangements in Hepatitis B Virus: Complex Structural Variations and Structural Variation Polymorphisms.

Authors:  Kei Fujiwara
Journal:  Viruses       Date:  2021-03-12       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.